| Dr Stella Y Chung, MS, MD | |
|
3535 W 13 Mile Rd Ste 555, Royal Oak, MI 48073-6770 | |
| (248) 551-2020 | |
| (248) 551-2267 |
| Full Name | Dr Stella Y Chung |
|---|---|
| Gender | Female |
| Speciality | Ophthalmology |
| Experience | 8 Years |
| Location | 3535 W 13 Mile Rd Ste 555, Royal Oak, Michigan |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194252551 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 4301503900 (Michigan) | Primary |
| 390200000X | Student In An Organized Health Care Education/training Program | (* (Not Available)) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| New York University Langone Medical Center | New york, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| New York University | 1355232422 | 4431 |
News Archive
Researchers at Rutgers and UMDNJ-Robert Wood Johnson Medical School have determined the structure of a protein that is the first line of defense in fighting viral infections including influenza, hepatitis C, West Nile, rabies, and measles.
Argos Therapeutics announced today that its Arcelis immunotherapy for the treatment of HIV, AGS-004, demonstrated positive outcomes with the primary endpoint of viral load control and a favorable safety and immunogenicity profile in a final analysis of a Phase 2a clinical trial.
University of Waterloo's Kimia Lab announced it will participate in the $126 million Industry Consortium for Image Guided Therapy.
Coronary CTA offers a low cost, non-invasive alternative to conventional angiography for evaluating patients who are suspected of having coronary artery disease; true even if the patients have calcified coronary artery plaques, according to a study performed at the Thomas Jefferson University Hospital, Philadelphia, PA.
› Verified 6 days ago
| Entity Name | New York University |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285826438 PECOS PAC ID: 1355232422 Enrollment ID: O20090822000026 |
News Archive
Researchers at Rutgers and UMDNJ-Robert Wood Johnson Medical School have determined the structure of a protein that is the first line of defense in fighting viral infections including influenza, hepatitis C, West Nile, rabies, and measles.
Argos Therapeutics announced today that its Arcelis immunotherapy for the treatment of HIV, AGS-004, demonstrated positive outcomes with the primary endpoint of viral load control and a favorable safety and immunogenicity profile in a final analysis of a Phase 2a clinical trial.
University of Waterloo's Kimia Lab announced it will participate in the $126 million Industry Consortium for Image Guided Therapy.
Coronary CTA offers a low cost, non-invasive alternative to conventional angiography for evaluating patients who are suspected of having coronary artery disease; true even if the patients have calcified coronary artery plaques, according to a study performed at the Thomas Jefferson University Hospital, Philadelphia, PA.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Stella Y Chung, MS, MD 100 Madison Ave, Morristown, NJ 07960-6136 Ph: () - | Dr Stella Y Chung, MS, MD 3535 W 13 Mile Rd Ste 555, Royal Oak, MI 48073-6770 Ph: (248) 551-2020 |
News Archive
Researchers at Rutgers and UMDNJ-Robert Wood Johnson Medical School have determined the structure of a protein that is the first line of defense in fighting viral infections including influenza, hepatitis C, West Nile, rabies, and measles.
Argos Therapeutics announced today that its Arcelis immunotherapy for the treatment of HIV, AGS-004, demonstrated positive outcomes with the primary endpoint of viral load control and a favorable safety and immunogenicity profile in a final analysis of a Phase 2a clinical trial.
University of Waterloo's Kimia Lab announced it will participate in the $126 million Industry Consortium for Image Guided Therapy.
Coronary CTA offers a low cost, non-invasive alternative to conventional angiography for evaluating patients who are suspected of having coronary artery disease; true even if the patients have calcified coronary artery plaques, according to a study performed at the Thomas Jefferson University Hospital, Philadelphia, PA.
› Verified 6 days ago
Tedi Begaj, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3555 W 13 Mile Rd Ste Ll-20, Royal Oak, MI 48073 Phone: 248-288-2280 | |
Dr. Robert J Mcdonald, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 32000 Woodward Ave, Royal Oak, MI 48073 Phone: 248-549-6000 Fax: 248-549-4923 | |
Huiyan Jin, Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 3535 W 13 Mile Rd, Royal Oak, MI 48073 Phone: 248-551-3643 | |
Dr. Sahal H. Saleh, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 3601 W 13 Mile Rd, Royal Oak, MI 48073 Phone: 248-551-3000 | |
Dr. George R Lesser, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 3535 W 13 Mile Rd, Suite 645, Royal Oak, MI 48073 Phone: 248-220-5252 Fax: 248-220-5261 | |
Dr. Tarek Shawky Hassan, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3555 W 13 Mile Rd, Ll-20, Royal Oak, MI 48073 Phone: 248-288-2280 Fax: 248-288-5644 | |
Dr. Safa Arfeen, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 3601 W 13 Mile Rd Ofc, Royal Oak, MI 48073 Phone: 248-551-6347 |